Table 1.
18F-FDG uptake in the nasopharynx
| Group | Min (%ID/mL) | Max (%ID/mL) | Average (%ID/mL) | Volume (ccm) |
|---|---|---|---|---|
| Control | 0.33 ± 0.03 | 1.09 ± 0.26 | 0.67 ± 0.06 | 0.0053 ± 0.00047 |
| DMSO | 0.29 ± 0.03 | 1.18 ± 0.31 | 0.71 ± 0.08 | 0.0055 ± 0.00050 |
| DNP | 0.38 ± 0.09 | 2.77 ± 1.15** | 1.06 ± 0.29* | 0.0043 ± 0.00047 |
* indicates p < 0.05; ** indicates p < 0.01. Final sample sizes for PET-CT analysis: Control group (n = 5), DMSO group (n = 6), DNP group (n = 8). All surviving animals completed PET-CT scanning at the 12-month endpoint. Statistical analysis was performed by one-way ANOVA followed by LSD post-hoc test